ROCKVILLE, Md.--(BUSINESS WIRE)--Oct. 27, 2005--Celera Genomics Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $16.7 million, or $0.23 per share, for the first quarter of fiscal 2006 ended September 30, 2005, compared to a net loss of $20.3 million, or $0.28 per share, for the first quarter of fiscal 2005. The first quarter fiscal 2006 results included a $4.5 million pre-tax gain from the sale of an investment. The first quarter fiscal 2005 results included a $4.5 million pre-tax charge related to the discontinuation of most of the operations of Paracel. All per share amounts refer to Applera Corporation-Celera Genomics Group Common Stock.
